Trial Profile
Safety and efficacy of ibrutinib in patients with chronic lymphocytic leukemia: A retrospective study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 23 Mar 2016
Price :
$35
*
At a glance
- Drugs Ibrutinib (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Adverse reactions; Therapeutic Use
- 23 Mar 2016 New trial record
- 18 Mar 2016 Results published in the Blood